As of January 22, 2025, Biotest (BIO.F) has a market cap of $1.43 billion USD. According to our data, Biotest is ranked No.4669 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.43 B |
69.27%
|
Dec 30, 2024 | $0.85 B |
-3.30%
|
Dec 29, 2023 | $0.87 B |
-0.93%
|
Dec 30, 2022 | $0.88 B |
0.94%
|
Dec 30, 2021 | $0.87 B |
47.22%
|
Dec 30, 2020 | $0.59 B |
50.39%
|
Dec 30, 2019 | $0.39 B |
-26.08%
|
Dec 28, 2018 | $0.53 B |
14.99%
|
Dec 29, 2017 | $0.46 B |
39.95%
|
Dec 30, 2016 | $0.33 B |
-12.04%
|
Dec 30, 2015 | $0.38 B |
-36.70%
|
Dec 30, 2014 | $0.60 B |
13.89%
|
Dec 30, 2013 | $0.52 B |
55.36%
|
Dec 28, 2012 | $0.34 B |
24.65%
|
Dec 30, 2011 | $0.27 B |
-14.91%
|
Dec 30, 2010 | $0.32 B |
24.68%
|
Dec 30, 2009 | $0.25 B |
-28.62%
|
Dec 30, 2008 | $0.36 B |
42.30%
|
Dec 28, 2007 | $0.25 B |
29.83%
|
Dec 29, 2006 | $0.19 B |
20.65%
|
Dec 30, 2005 | $0.16 B |
103.75%
|
Dec 31, 2004 | $78.60 M |
64.38%
|
Dec 31, 2003 | $47.81 M |
48.98%
|
Dec 31, 2002 | $32.09 M |
-63.43%
|
Dec 31, 2001 | $87.77 M |
-11.26%
|
Dec 29, 2000 | $98.90 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
CSL
CSL.AX
|
$82.06 B |
-0.963 B
|
Australia
|
Grifols
GRFS
|
$5.81 B |
3.899 B
|
Spain
|
Baxter
BAX
|
$16.26 B |
-0.000 M
|
USA
|
Takeda Pharmaceutical
TAK
|
$41.01 B |
-0.002 M
|
Japan
|
Kamada
KMDA
|
$0.43 B |
0.000 M
|
Israel
|
ADMA Biologics
ADMA
|
$3.89 B |
0.000 M
|
USA
|
Biolife Solutions
BLFS
|
$1.29 B |
0.000 M
|
USA
|
Emergent BioSolutions
EBS
|
$0.58 B |
-0.000 M
|
USA
|
Haemonetics
HAE
|
$3.68 B |
0.000 M
|
USA
|
Cerus
CERS
|
$0.33 B |
0.000 M
|
USA
|
Market Cap | = | BIO.F Stock Price | * | BIO.F Shares Outstanding |
= | $42.73 | * | 19.79 M | |
= | $1.43 B |